Microbot Medical Inc. (MBOT)
USD 0.97
(-3.69%)
USD 0.97
(-3.69%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -10.74 Million USD | -100.01% |
| 2022 | 104.83 Million USD | 1030.27% |
| 2021 | -11.26 Million USD | -21.84% |
| 2020 | -9.24 Million USD | -25.84% |
| 2019 | -7.35 Million USD | -1.52% |
| 2018 | -7.24 Million USD | 4.6% |
| 2017 | -7.58 Million USD | 21.46% |
| 2016 | -9.66 Million USD | 73.46% |
| 2015 | -36.41 Million USD | -11.22% |
| 2014 | -32.74 Million USD | -23.84% |
| 2013 | -26.43 Million USD | 7.2% |
| 2012 | -28.49 Million USD | -33.59% |
| 2011 | -21.32 Million USD | 15.51% |
| 2010 | -25.24 Million USD | 6.6% |
| 2009 | -27.02 Million USD | 7.08% |
| 2008 | -29.08 Million USD | -16.24% |
| 2007 | -25.02 Million USD | -32.06% |
| 2006 | -18.94 Million USD | -61.42% |
| 2005 | -11.73 Million USD | 23.43% |
| 2004 | -15.33 Million USD | -24.73% |
| 2003 | -12.29 Million USD | -18.58% |
| 2002 | -10.36 Million USD | -200.74% |
| 2001 | -3.44 Million USD | 69.61% |
| 2000 | -11.34 Million USD | 27.8% |
| 1999 | -15.7 Million USD | -24.67% |
| 1998 | -12.6 Million USD | 30.39% |
| 1997 | -18.1 Million USD | -31.16% |
| 1996 | -13.8 Million USD | -55.06% |
| 1995 | -8.9 Million USD | 46.06% |
| 1994 | -16.5 Million USD | -32.0% |
| 1993 | -12.5 Million USD | -25.0% |
| 1992 | -10 Million USD | -56.25% |
| 1991 | -6.4 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -2.46 Million USD | -3.96% |
| 2024 Q1 | -2.37 Million USD | 24.83% |
| 2023 Q1 | -2.78 Million USD | -102.35% |
| 2023 FY | -10.74 Million USD | -110.24% |
| 2023 Q4 | -3.15 Million USD | -28.95% |
| 2023 Q2 | -2.28 Million USD | 17.94% |
| 2023 Q3 | -2.44 Million USD | -6.95% |
| 2022 FY | 104.83 Million USD | 1030.27% |
| 2022 Q4 | 118.47 Million USD | 3522.01% |
| 2022 Q3 | -3.46 Million USD | 1.45% |
| 2022 Q2 | -3.51 Million USD | -9.71% |
| 2022 Q1 | -3.2 Million USD | 17.03% |
| 2021 FY | -11.26 Million USD | -21.84% |
| 2021 Q1 | -2.38 Million USD | 9.44% |
| 2021 Q2 | -2.51 Million USD | -5.15% |
| 2021 Q3 | -2.55 Million USD | -1.75% |
| 2021 Q4 | -3.85 Million USD | -51.04% |
| 2020 Q1 | -2.2 Million USD | -17.91% |
| 2020 FY | -9.24 Million USD | -25.84% |
| 2020 Q4 | -2.63 Million USD | -6.67% |
| 2020 Q3 | -2.47 Million USD | -33.26% |
| 2020 Q2 | -1.85 Million USD | 15.87% |
| 2019 Q1 | -1.96 Million USD | 7.89% |
| 2019 Q3 | -1.87 Million USD | -21.53% |
| 2019 FY | -7.35 Million USD | -1.52% |
| 2019 Q4 | -1.87 Million USD | 0.21% |
| 2019 Q2 | -1.54 Million USD | 21.37% |
| 2018 Q2 | -1.89 Million USD | -28.86% |
| 2018 FY | -7.24 Million USD | 4.6% |
| 2018 Q1 | -1.46 Million USD | 7.44% |
| 2018 Q4 | -2.12 Million USD | -21.73% |
| 2018 Q3 | -1.74 Million USD | 7.61% |
| 2017 FY | -7.58 Million USD | 21.46% |
| 2017 Q1 | -1.3 Million USD | -180.14% |
| 2017 Q2 | -3.5 Million USD | -168.4% |
| 2017 Q3 | -1.18 Million USD | 66.16% |
| 2017 Q4 | -1.58 Million USD | -33.7% |
| 2016 Q2 | 2.51 Million USD | 126.31% |
| 2016 Q1 | -9.56 Million USD | -6.71% |
| 2016 FY | -9.66 Million USD | 73.46% |
| 2016 Q4 | 1.63 Million USD | 138.39% |
| 2016 Q3 | -4.24 Million USD | -268.87% |
| 2015 FY | -36.41 Million USD | -11.22% |
| 2015 Q2 | -8.46 Million USD | 9.51% |
| 2015 Q1 | -9.35 Million USD | 8.76% |
| 2015 Q3 | -9.64 Million USD | -13.96% |
| 2015 Q4 | -8.96 Million USD | 7.08% |
| 2014 Q4 | -10.24 Million USD | -271.74% |
| 2014 Q1 | -7.62 Million USD | -9.45% |
| 2014 Q3 | -2.75 Million USD | 77.24% |
| 2014 Q2 | -12.11 Million USD | -58.99% |
| 2014 FY | -32.74 Million USD | -23.84% |
| 2013 FY | -26.43 Million USD | 7.2% |
| 2013 Q2 | -5.86 Million USD | 8.54% |
| 2013 Q4 | -6.96 Million USD | 3.19% |
| 2013 Q3 | -7.19 Million USD | -22.54% |
| 2013 Q1 | -6.41 Million USD | -132.61% |
| 2012 Q2 | 834 Thousand USD | 108.15% |
| 2012 FY | -28.49 Million USD | -33.59% |
| 2012 Q4 | -2.75 Million USD | 83.12% |
| 2012 Q1 | -10.22 Million USD | -41.84% |
| 2012 Q3 | -16.33 Million USD | -2058.85% |
| 2011 FY | -21.32 Million USD | 15.51% |
| 2011 Q1 | -5.74 Million USD | 35.84% |
| 2011 Q2 | -4.03 Million USD | 29.79% |
| 2011 Q3 | -4.33 Million USD | -7.41% |
| 2011 Q4 | -7.21 Million USD | -66.4% |
| 2010 Q2 | -4.61 Million USD | 24.72% |
| 2010 Q3 | -5.55 Million USD | -20.43% |
| 2010 Q1 | -6.12 Million USD | -17.01% |
| 2010 Q4 | -8.95 Million USD | -61.32% |
| 2010 FY | -25.24 Million USD | 6.6% |
| 2009 Q3 | -5.14 Million USD | 30.16% |
| 2009 FY | -27.02 Million USD | 7.08% |
| 2009 Q1 | -9.28 Million USD | 7.94% |
| 2009 Q4 | -5.23 Million USD | -1.73% |
| 2009 Q2 | -7.36 Million USD | 20.63% |
| 2008 Q4 | -10.08 Million USD | -75.53% |
| 2008 Q3 | -5.74 Million USD | 14.47% |
| 2008 Q2 | -6.71 Million USD | -2.6% |
| 2008 Q1 | -6.54 Million USD | 16.36% |
| 2008 FY | -29.08 Million USD | -16.24% |
| 2007 Q2 | -5.42 Million USD | -17.41% |
| 2007 Q1 | -4.61 Million USD | 21.73% |
| 2007 Q3 | -7.15 Million USD | -31.89% |
| 2007 Q4 | -7.82 Million USD | -9.39% |
| 2007 FY | -25.02 Million USD | -32.06% |
| 2006 FY | -18.94 Million USD | -61.42% |
| 2006 Q1 | -4.19 Million USD | 3.11% |
| 2006 Q4 | -5.9 Million USD | -21.37% |
| 2006 Q3 | -4.86 Million USD | -21.9% |
| 2006 Q2 | -3.98 Million USD | 4.86% |
| 2005 FY | -11.73 Million USD | 23.43% |
| 2005 Q4 | -4.32 Million USD | -4518.85% |
| 2005 Q3 | -93.69 Thousand USD | 97.58% |
| 2005 Q2 | -3.86 Million USD | -12.16% |
| 2005 Q1 | -3.44 Million USD | 29.89% |
| 2004 FY | -15.33 Million USD | -24.73% |
| 2004 Q2 | -3.3 Million USD | -19.2% |
| 2004 Q3 | -4.33 Million USD | -31.34% |
| 2004 Q4 | -4.91 Million USD | -13.41% |
| 2004 Q1 | -2.77 Million USD | 41.54% |
| 2003 Q1 | -2.4 Million USD | -36.01% |
| 2003 Q4 | -4.73 Million USD | -95.09% |
| 2003 Q3 | -2.42 Million USD | 10.45% |
| 2003 FY | -12.29 Million USD | -18.58% |
| 2003 Q2 | -2.71 Million USD | -12.58% |
| 2002 Q2 | -3.05 Million USD | -8.82% |
| 2002 Q4 | -1.77 Million USD | 35.0% |
| 2002 Q1 | -2.81 Million USD | 20.22% |
| 2002 FY | -10.36 Million USD | -200.74% |
| 2002 Q3 | -2.72 Million USD | 10.87% |
| 2001 Q1 | 268.54 Thousand USD | 104.15% |
| 2001 Q4 | -3.52 Million USD | -97.11% |
| 2001 FY | -3.44 Million USD | 69.61% |
| 2001 Q3 | -1.78 Million USD | -212.08% |
| 2001 Q2 | 1.59 Million USD | 493.78% |
| 2000 Q2 | -531.7 Thousand USD | 70.37% |
| 2000 Q3 | -2.53 Million USD | -377.56% |
| 2000 Q4 | -6.47 Million USD | -155.05% |
| 2000 FY | -11.34 Million USD | 27.8% |
| 2000 Q1 | -1.79 Million USD | 65.55% |
| 1999 Q3 | -6.7 Million USD | -272.22% |
| 1999 FY | -15.7 Million USD | -24.67% |
| 1999 Q1 | -1.9 Million USD | 13.64% |
| 1999 Q2 | -1.8 Million USD | 5.26% |
| 1999 Q4 | -5.2 Million USD | 22.26% |
| 1998 FY | -12.6 Million USD | 30.39% |
| 1998 Q4 | -2.2 Million USD | 24.14% |
| 1998 Q3 | -2.9 Million USD | 27.5% |
| 1998 Q2 | -4 Million USD | -14.29% |
| 1998 Q1 | -3.5 Million USD | -218.18% |
| 1997 FY | -18.1 Million USD | -31.16% |
| 1997 Q4 | -1.1 Million USD | 90.91% |
| 1997 Q3 | -12.1 Million USD | -1628.57% |
| 1997 Q2 | -700 Thousand USD | 83.33% |
| 1997 Q1 | -4.2 Million USD | 6.67% |
| 1996 FY | -13.8 Million USD | -55.06% |
| 1996 Q3 | -3.6 Million USD | -33.33% |
| 1996 Q2 | -2.7 Million USD | 10.0% |
| 1996 Q1 | -3 Million USD | 44.44% |
| 1996 Q4 | -4.5 Million USD | -25.0% |
| 1995 Q2 | -2.9 Million USD | -252.63% |
| 1995 FY | -8.9 Million USD | 46.06% |
| 1995 Q1 | 1.9 Million USD | 141.3% |
| 1995 Q4 | -5.4 Million USD | -116.0% |
| 1995 Q3 | -2.5 Million USD | 13.79% |
| 1994 Q2 | -4.4 Million USD | -62.96% |
| 1994 FY | -16.5 Million USD | -32.0% |
| 1994 Q1 | -2.7 Million USD | -58.82% |
| 1994 Q4 | -4.6 Million USD | 4.17% |
| 1994 Q3 | -4.8 Million USD | -9.09% |
| 1993 Q2 | -3.8 Million USD | -11.76% |
| 1993 Q3 | -3.7 Million USD | 2.63% |
| 1993 Q4 | -1.7 Million USD | 54.05% |
| 1993 FY | -12.5 Million USD | -25.0% |
| 1993 Q1 | -3.4 Million USD | -6.25% |
| 1992 Q1 | -2 Million USD | -25.0% |
| 1992 FY | -10 Million USD | -56.25% |
| 1992 Q3 | -2.5 Million USD | -8.7% |
| 1992 Q2 | -2.3 Million USD | -15.0% |
| 1992 Q4 | -3.2 Million USD | -28.0% |
| 1991 FY | -6.4 Million USD | 0.0% |
| 1991 Q2 | -1.6 Million USD | 0.0% |
| 1991 Q1 | -1.6 Million USD | 0.0% |
| 1991 Q4 | -1.6 Million USD | 0.0% |
| 1991 Q3 | -1.6 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Akoya Biosciences, Inc. | -63.32 Million USD | 83.039% |
| AngioDynamics, Inc. | -184.34 Million USD | 94.174% |
| AtriCure, Inc. | -30.43 Million USD | 64.715% |
| Avinger, Inc. | -18.32 Million USD | 41.376% |
| Azenta, Inc. | -14.25 Million USD | 24.669% |
| BioLife Solutions, Inc. | -66.42 Million USD | 83.832% |
| The Cooper Companies, Inc. | 294.2 Million USD | 103.651% |
| Daxor Corporation | 280.64 Thousand USD | 3926.967% |
| Ekso Bionics Holdings, Inc. | -15.19 Million USD | 29.333% |
| Femasys Inc. | -14.24 Million USD | 24.616% |
| GlucoTrack, Inc. | -7.09 Million USD | -51.332% |
| Harvard Bioscience, Inc. | -3.41 Million USD | -214.495% |
| Hologic, Inc. | 789.5 Million USD | 101.36% |
| ICU Medical, Inc. | -29.65 Million USD | 63.784% |
| Intuitive Surgical, Inc. | 1.79 Billion USD | 100.597% |
| KORU Medical Systems, Inc. | -13.74 Million USD | 21.84% |
| LeMaitre Vascular, Inc. | 30.1 Million USD | 135.675% |
| Innovative Eyewear, Inc. | -6.66 Million USD | -61.178% |
| Innovative Eyewear, Inc. | -6.66 Million USD | -61.178% |
| Masimo Corporation | 81.5 Million USD | 113.178% |
| Meihua International Medical Technologies Co., Ltd. | 11.62 Million USD | 192.384% |
| Merit Medical Systems, Inc. | 94.41 Million USD | 111.376% |
| Nephros, Inc. | -1.57 Million USD | -581.905% |
| NovoCure Limited | -207.04 Million USD | 94.813% |
| NEXGEL, Inc. | -3.15 Million USD | -240.196% |
| NEXGEL, Inc. | -3.15 Million USD | -240.196% |
| Singular Genomics Systems, Inc. | -94.82 Million USD | 88.673% |
| OraSure Technologies, Inc. | 53.65 Million USD | 120.017% |
| Pro-Dex, Inc. | 2.12 Million USD | 604.937% |
| Pulse Biosciences, Inc. | -42.21 Million USD | 74.556% |
| Predictive Oncology Inc. | -13.98 Million USD | 23.198% |
| Precision Optics Corporation, Inc. | -2.95 Million USD | -263.898% |
| QuidelOrtho Corporation | -10.1 Million USD | -6.337% |
| Repligen Corporation | 41.57 Million USD | 125.832% |
| Sanara MedTech Inc. | -4.3 Million USD | -149.582% |
| STAAR Surgical Company | 21.34 Million USD | 150.312% |
| Sharps Technology, Inc. | -9.84 Million USD | -9.128% |
| Utah Medical Products, Inc. | 16.63 Million USD | 164.563% |
| DENTSPLY SIRONA Inc. | -132 Million USD | 91.864% |
| Jin Medical International Ltd. | 2.87 Million USD | 473.146% |